Decoding the structural basis of ligand recognition and biased signaling in the motilin receptor

Chongzhao You1, Mengting Jiang2, Tianyu Gao3

  • 1The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Cell Reports
|February 23, 2025
PubMed

Insights

Structural insights into the motilin receptor (MTLR) reveal distinct binding mechanisms for agonists like azithromycin and DS-3801b. These findings guide the development of novel gastrointestinal prokinetic drugs.

Area of Science:

  • Structural Biology
  • Pharmacology
  • Gastroenterology

Background:

  • The motilin receptor (MTLR) is a therapeutic target for gastrointestinal (GI) disorders, including gastroparesis.
  • Developing effective MTLR agonists is hindered by drug tolerance and signaling bias.
  • Understanding MTLR ligand interactions is crucial for designing improved prokinetic agents.

Purpose of the Study:

  • To elucidate the structural basis of ligand recognition and signaling selectivity at the MTLR.
  • To provide insights for the rational design of next-generation GI prokinetic drugs.

Main Methods:

  • Cryoelectron microscopy (cryo-EM) was employed to determine the structures of MTLR bound to azithromycin and DS-3801b.
  • Analysis of ligand-receptor interactions and key structural motifs involved in signaling.

Main Results:

  • Distinct binding modes were observed for the macrolide azithromycin (deep orthosteric pocket) and the non-macrolide DS-3801b (clamp-like conformation).
  • Extracellular loop 2 (ECL2) plays a critical role in determining ligand specificity and modulating G-protein and β-arrestin signaling.
  • The "D2.60R2.63S3.28" motif and TM6/7 interactions are identified as key determinants of signaling selectivity.

Conclusions:

  • The study reveals novel structural mechanisms of MTLR activation by different agonists.
  • These findings provide a structural foundation for designing MTLR-targeting drugs with improved efficacy and safety profiles for GI motility disorders.

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.1K